Baker Tilly’s life sciences team has more than 15 years of experience delivering global spend transparency services to life sciences, medical device and pharmaceutical companies. We specialize in taking what appears to be a complex web of disparate source systems, data and requirements and simplifying it through a streamlined approach.
Our specialized professionals have a deep understanding of spend transparency regulations from states, Open Payments in the US, and global spend transparency requirements through EFPIA, French Sunshine Act and other countries with spend transparency laws. We know reporting needs from what to where to when.
We understand organizations need solutions aligned with their stage of maturity and can advise companies on the type of solution needed at each stage of development:
Our focus on value protection means we remain engaged with our clients to support their ongoing strategy execution, but advise on ways to execute the right way, within the spirit of spend transparency guidelines.